Innovacell

Operator of a biotechnology company intended to develop, produce, and market cell therapies for treating fecal and urinary incontinence. The company offers a minimally invasive administration of cell ...

Healthcare

Tokyo, Japan

45 employees

Website

Valuation

$216.7M

Market implied

Share Price

N/A

Total Raised

$120.2M

Last Round

N/A

Investors

+26 other investors

View all 26 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Innovacell's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required